$45.37 Million in Sales Expected for Aterian, Inc. (NASDAQ:ATER) This Quarter

Equities research analysts expect Aterian, Inc. (NASDAQ:ATERGet Rating) to report sales of $45.37 million for the current quarter, according to Zacks. Two analysts have provided estimates for Aterian’s earnings, with the lowest sales estimate coming in at $40.05 million and the highest estimate coming in at $50.70 million. Aterian reported sales of $48.14 million during the same quarter last year, which would suggest a negative year-over-year growth rate of 5.8%. The company is scheduled to issue its next quarterly earnings report on Monday, January 1st.

On average, analysts expect that Aterian will report full year sales of $264.21 million for the current year, with estimates ranging from $262.53 million to $265.90 million. For the next fiscal year, analysts forecast that the business will post sales of $317.59 million, with estimates ranging from $300.90 million to $334.28 million. Zacks’ sales calculations are a mean average based on a survey of research analysts that cover Aterian.

Aterian (NASDAQ:ATERGet Rating) last announced its earnings results on Tuesday, March 8th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.31) by $0.20. Aterian had a negative return on equity of 42.93% and a negative net margin of 94.74%. During the same period in the previous year, the firm posted ($0.33) earnings per share.

A number of brokerages have recently issued reports on ATER. Alliance Global Partners cut their target price on Aterian from $9.00 to $4.50 in a research note on Friday, March 11th. BTIG Research decreased their price objective on Aterian from $9.00 to $5.00 and set a “buy” rating on the stock in a report on Wednesday, March 9th. DA Davidson reduced their target price on Aterian from $14.00 to $7.00 in a report on Wednesday, March 9th. Finally, Zacks Investment Research upgraded Aterian from a “hold” rating to a “buy” rating and set a $4.50 target price on the stock in a report on Tuesday. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $13.83.

In other news, insider Yaniv Zion Sarig sold 166,127 shares of the stock in a transaction on Wednesday, March 23rd. The stock was sold at an average price of $2.68, for a total value of $445,220.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 4.80% of the company’s stock.

Several large investors have recently modified their holdings of the company. Hudson Bay Capital Management LP lifted its stake in Aterian by 327.3% during the third quarter. Hudson Bay Capital Management LP now owns 3,347,184 shares of the company’s stock worth $34,709,000 after purchasing an additional 2,563,883 shares during the period. BlackRock Inc. grew its holdings in shares of Aterian by 18.5% in the 4th quarter. BlackRock Inc. now owns 1,833,525 shares of the company’s stock valued at $7,535,000 after buying an additional 285,651 shares during the period. Meitav Dash Investments Ltd. grew its holdings in shares of Aterian by 183.1% in the 3rd quarter. Meitav Dash Investments Ltd. now owns 754,886 shares of the company’s stock valued at $8,175,000 after buying an additional 488,219 shares during the period. Geode Capital Management LLC lifted its position in Aterian by 41.9% in the 4th quarter. Geode Capital Management LLC now owns 584,904 shares of the company’s stock valued at $2,403,000 after acquiring an additional 172,652 shares in the last quarter. Finally, Morgan Stanley bought a new stake in Aterian during the 2nd quarter worth about $5,227,000. 24.29% of the stock is currently owned by institutional investors.

Aterian stock traded up $0.65 during mid-day trading on Wednesday, reaching $5.65. 161,197,379 shares of the company were exchanged, compared to its average volume of 10,655,211. The firm has a market cap of $350.83 million, a PE ratio of -0.74 and a beta of 2.71. The firm’s 50-day simple moving average is $3.05 and its two-hundred day simple moving average is $4.69. Aterian has a twelve month low of $2.10 and a twelve month high of $28.00.

Aterian Company Profile (Get Rating)

Aterian, Inc, together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. The company provides Artificial Intelligence Marketplace e-Commerce Engine, a software technology platform, which uses machine learning, natural language processing, and data analytics to design, develop, market, and sell products.

Read More

Get a free copy of the Zacks research report on Aterian (ATER)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.